Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$3.83−0.17 (-4.25%)

Close on Nov 13, 2026Market cap $35.55MP/E –Yield –

Exozymes ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Exozymes has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?